Martin Imaging

Medical Devices, 981 Highway 98 E, Destin, Florida, 32541, United States, 1-10 Employees

Phone Number: +16*********

Who is MARTIN IMAGING

By expanding access to this cutting-edge technology, Martin Imaging, Inc. is seeking to improve the standard of care for several currently underserved populations, particularly women, for...

Get Full Access

Headquarters: 981 Highway 98 E, Destin, Florida, 32541, United States
Employees: 1-10
Revenue: Under $1 Million

Industry: Medical Devices

Does something look wrong? Fix it. | View contact records from MARTIN IMAGING

Martin Imaging Org Chart and Mapping

Employees

Lourdes Cosio

Vice President for Client Development

Email
Phone

See Full Org Chart

View Email Formats for Martin Imaging

You are signed out

Join Now

Free credits every month

Frequently Asked Questions Regarding Martin Imaging

Answer: Martin Imaging's headquarters are located at 981 Highway 98 E, Destin, Florida, 32541, United States

Answer: By expanding access to this cutting-edge technology, Martin Imaging, Inc. is seeking to improve the standard of care for several currently underserved populations, particularly women, for whom the current generation of technologies is inadequate for proper diagnosis. Positron Emission Tomography (PET) Myocardial Perfusion Imaging (MPI) is the preferred test when compared to other methods of cardiac assessment due to superior image quality, significantly lower radiation exposure, the ability to identify and quantify risk, and the ability to successfully guide therapy in patients with known or suspected coronary artery disease (CAD). The high sensitivity, specificity and diagnostic accuracy allows PET MPI to outperform other non-invasive approaches used to evaluate disease, especially in women, obese patients and those who have previously undergone Coronary Artery Bypass Grafts (CABG). Despite the superior performance of PET MPI in all patient types as a strong prognostic and risk stratification tool, it is still significantly underutilized as a modality, due to the limited number of Cardiac PET programs currently in existence throughout the United States. This low adoption rate continues to limit access to care and testing for patients who might otherwise benefit from a PET MPI. In addition to cardiology, PET imaging is an important diagnostic, planning and treatment tool for oncology and neurology. While such procedures are widely used in hospital and academic settings, they remain underutilized in outpatient office settings, with limited access in the rural and community settings. Nuclear cardiologists in private or integrated practices, neurologists specializing in the aging brain/memory clinics, oncologists with older systems looking to upgrade to newer advanced technologies, and radiation oncologists looking to bring PET/CT imaging for treatment planning and staging to their current radiation therapy setting, all benefit from the improved patient outcomes.